Prime MedTech
Timeline
16 events since 2019Board
Filings
Financial
Establishments
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 28 days before the deadline
2025
Highest result from 2019 to 2025 net €94,354 ▲25% The operating result of €127,333 and the net result of €94,354 are both a record.
Annual accounts 2024 filed PDFmicro format · 21 days before the deadline
2024
Equity above €200,000 equity €202,975 ▲14.3% Equity rises from €177,514 to €202,975.
Change of role: , from manager to directorLegal-form conversion: from private limited company (pre-2019) to private limited company · holds all the shares · General meeting of 27-06-20247 points ▸
- General meeting, 27-06-2024
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- holds all the shares
- 100 shares
- Director resignation, (manager)
- Director appointment,
- Registered office clause, Kwikstaartlaan 11, 2610 Antwerpen (Wilrijk)
- The deed holds 2 more points.
Annual accounts 2023 filed PDFmicro format · 35 days before the deadline
2023
Liquidity more than 6 times current ratio 10.16 The current ratio rises from 1.58 to 10.16. Short-term debt falls from €195,996 to €19,274.
Annual accounts 2022 filed PDFmicro format · 7 days before the deadline
2022
Annual accounts 2021 filed PDFmicro format · 27 days before the deadline
2021
Weakest financial year net €38,740 ▼41.4% The net result drops to €38,740, the lowest from 2019 to 2025. It recovers the following year.
Equity above €150,000 equity €193,193 ▲30.2% With a profit in every financial year since 2019, equity grows to €193,193.
Annual accounts 2020 filed PDFmicro format · 32 days before the deadline
2020
Equity above €100,000 equity €148,353 ▲80.3% With a profit in every financial year since 2019, equity grows to €148,353.
Annual accounts 2019 filed PDFmicro format · 29 days before the deadline
2019
First establishment Kwikstaartlaan 11, Antwerp
IncorporationFounding capital of €18,600, 100 shares, €12,400 paid up · Founder: · Appointment: (manager) · published on 22-03-20194 points ▸
- Founder,
- Founding capital, €18,600, 100 shares
- holds 100 shares
- Director appointment, (manager)
- The deed holds 5 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank